Studies on two new vitamin D analogs, EB 1089 and KH 1060: Effects on bone resorption and osteoclast recruitment in vitro
- 31 October 1995
- Vol. 17 (4) , 391-395
- https://doi.org/10.1016/s8756-3282(95)00246-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Increased biological activity of 20-EPI-1,25-dihydroxyvitamin D3 is due to reduced catabolism and altered protein bindingBiochemical Pharmacology, 1994
- A dialogue on analogues Newer vitamin-D drugs for use in bone disease, psoriasis, and cancerTrends in Endocrinology & Metabolism, 1993
- Vitamin D analogs with low affinity for the vitamin D binding protein: Enhanced in vitro and decreased in vivo activityJournal of Bone and Mineral Research, 1991
- 20-EPI-vitamin D3 analogues: A novel class of potent regulators of cell growth and immune responsesBiochemical Pharmacology, 1991
- Calcipotriol (MC 903): Pharmacokinetics in rats and biological activities of metabolites: A comparative study with 1,25(OH)2D3Biochemical Pharmacology, 1991
- On the Mechanisms for the Selective Action of Vitamin D Analogs*Endocrinology, 1991
- Generation of Osteoclastic Function in Mouse Bone Marrow Cultures: Multinuclearity and Tartrate- Resistant Acid Phosphatase Are Unreliable Markers for Osteoclastic Differentiation*Endocrinology, 1989
- Vitamin D Uptake and Metabolism by Perfused Rat Liver: Influences of Carrier Proteins*Endocrinology, 1988
- Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivoBiochemical Pharmacology, 1988
- Modifications of the mouse calvarial technique improve the responsiveness to stimulators of bone resorptionJournal of Bone and Mineral Research, 1987